- Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor
-
Kim KH, Kim JH, Chang YS, Lee TG, Kim JW, Lew YJ
- KMID: 2363805
- Korean J Ophthalmol.
- 2015 Oct;29(5):315-324.
- doi: 10.3341/kjo.2015.29.5.315
PURPOSE: To evaluate the long-term outcomes of intravitreal anti-vascular endothelial growth factor (VEGF) monotherapy for patients diagnosed with submacular hemorrhage secondary to exudative age-related macular degeneration. METHODS: This retrospective, observational study... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas
-
Lee JP, Park JS, Kwon OW, You YS, Kim SH
- KMID: 2373974
- Korean J Ophthalmol.
- 2016 Jun;30(3):192-197.
- doi: 10.3341/kjo.2016.30.3.192
PURPOSE: To evaluate the visual and anatomical outcomes for neovascular age-related macular degeneration with submacular hemorrhage after intravitreal injections of tenecteplase (TNK), anti-vascular endothelial growth factor (VEGF) and expansile gas. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
